Metagenomi earnings were -$87.1M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest MGX earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$19.9M, down 20.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MGX reported annual earnings of -$78.1M, with 14.4% growth. The next MGX earnings date is Nov 12, 2025.
On MGX's earnings call on Invalid Date, Metagenomi (NASDAQ: MGX) reported Q2 2025 earnings per share (EPS) of -$0.54, up 86.21% year over year. Total MGX earnings for the quarter were -$19.91 million. In the same quarter last year, Metagenomi's earnings per share (EPS) was -$0.29.
The next MGX earnings call is Invalid Date. Add MGX to your watchlist to be reminded of Metagenomi's next earnings date.
Is Metagenomi profitable or losing money?
As of the last Metagenomi earnings report, Metagenomi is currently losing money. Metagenomi's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$87.12 million, a 16.16% increase year over year.
What was MGX's earnings growth in the past year?
As of Metagenomi's earnings date in Invalid Date, Metagenomi's earnings has grown year over year. MGX earnings in the past year totalled -$87.12 million.
What are Metagenomi's earnings expectations?
The current EPS estimate for Metagenomi's earnings report in Invalid Date is -$0.80.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.